Cabaletta Bio (CABA) Total Current Liabilities (2018 - 2026)
Cabaletta Bio (CABA) posted quarterly Total Current Liabilities of $50.2 million for Q4 2025, up 85.16% year-over-year from $27.1 million in Q4 2024, and up 9.66% quarter-over-quarter from $45.7 million in Q3 2025.
Cabaletta Bio (CABA) Total Current Liabilities (2018 - 2026) Analysis & Trends
Cabaletta Bio's Total Current Liabilities history runs 8 years deep, the most recent figure standing at $50.2 million for Q4 2025.
- In Q4 2025, Total Current Liabilities rose 85.16% year-over-year to $50.2 million; the TTM figure through Dec 2025 stood at $50.2 million (up 85.16% YoY), while the FY2025 annual figure was $50.2 million, up 85.16% from the prior year.
- Total Current Liabilities for Q4 2025 stood at $50.2 million, up from $45.7 million in the prior quarter.
- The five-year high for Total Current Liabilities was $50.2 million in Q4 2025, with the low at $4.0 million in Q1 2021.
- The 5-year median for Total Current Liabilities is $10.1 million (2022), against an average of $17.7 million.
- The sharpest annual moves came in 2022 and 2025: Total Current Liabilities dropped 3.69% in 2022, then jumped 132.08% in 2025.
- Cabaletta Bio's Total Current Liabilities stood at $8.4 million in 2021, then climbed by 13.23% to $9.5 million in 2022, then jumped by 68.55% to $16.0 million in 2023, then jumped by 69.35% to $27.1 million in 2024, then soared by 85.16% to $50.2 million in 2025.
- Business Quant data shows CABA's Total Current Liabilities at $50.2 million in Q4 2025, $45.7 million in Q3 2025, and $41.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Cabaletta Bio | 466.25 Mn | 466.25 Mn | - | 39.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39.91 Mn |
| Dec 31, 2025 | 50.15 Mn |
| Sep 30, 2025 | 45.74 Mn |
| Jun 30, 2025 | 41.54 Mn |
| Mar 31, 2025 | 33.99 Mn |
| Dec 31, 2024 | 27.09 Mn |
| Sep 30, 2024 | 22.88 Mn |
| Jun 30, 2024 | 17.90 Mn |
| Mar 31, 2024 | 17.97 Mn |
| Dec 31, 2023 | 15.99 Mn |
| Sep 30, 2023 | 10.62 Mn |
| Jun 30, 2023 | 8.48 Mn |
| Mar 31, 2023 | 9.31 Mn |
| Dec 31, 2022 | 9.49 Mn |
| Sep 30, 2022 | 5.80 Mn |
| Jun 30, 2022 | 6.49 Mn |
| Mar 31, 2022 | 6.94 Mn |
| Dec 31, 2021 | 8.38 Mn |
| Sep 30, 2021 | 6.02 Mn |
| Jun 30, 2021 | 5.60 Mn |